192 related articles for article (PubMed ID: 20230219)
21. Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay.
van der Haar Àvila I; Marmol P; Kiessling R; Pico de Coaña Y
Methods Mol Biol; 2019; 1913():167-179. PubMed ID: 30666606
[TBL] [Abstract][Full Text] [Related]
22. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
23. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
24. Measuring human mast cell-mediated cytotoxicity against human tumour cells: three-colour flow cytometry using monoclonal antibody target staining with annexin V / propidium iodide co-labelling of death.
Ozdemir O
Allergol Immunopathol (Madr); 2011; 39(5):259-66. PubMed ID: 21236549
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.
Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
BMC Immunol; 2019 May; 20(1):14. PubMed ID: 31077146
[TBL] [Abstract][Full Text] [Related]
26. IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34
Van der Meer JMR; Maas RJA; Guldevall K; Klarenaar K; de Jonge PKJD; Evert JSH; van der Waart AB; Cany J; Safrit JT; Lee JH; Wagena E; Friedl P; Önfelt B; Massuger LF; Schaap NPM; Jansen JH; Hobo W; Dolstra H
Cancer Immunol Immunother; 2021 May; 70(5):1305-1321. PubMed ID: 33140189
[TBL] [Abstract][Full Text] [Related]
27. High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML).
Wang L; Gao L; Xu S; Gong S; Liu M; Qiu H; Xu X; Ni X; Chen L; Lu S; Chen J; Song X; Zhang W; Yang J; Hu X; Wang J
Ann Hematol; 2014 Oct; 93(10):1685-94. PubMed ID: 24844781
[TBL] [Abstract][Full Text] [Related]
28. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays.
Cholujová D; Jakubíková J; Kubes M; Arendacká B; Sapák M; Ihnatko R; Sedlák J
Immunobiology; 2008; 213(8):629-40. PubMed ID: 18765168
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents.
Ikezoe T; Yang J; Nishioka C; Kojima S; Takeuchi A; Phillip Koeffler H; Yokoyama A
Int J Cancer; 2011 May; 128(10):2317-25. PubMed ID: 21128225
[TBL] [Abstract][Full Text] [Related]
31. Measuring natural killer cell cytotoxicity by flow cytometry.
Wong WY; Wong H; Cheung SP; Chan E
Pathology; 2019 Apr; 51(3):286-291. PubMed ID: 30803738
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays.
Langhans B; Ahrendt M; Nattermann J; Sauerbruch T; Spengler U
J Immunol Methods; 2005 Nov; 306(1-2):161-8. PubMed ID: 16202423
[TBL] [Abstract][Full Text] [Related]
33. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometry evaluation of cell-mediated cytotoxicity.
Zarcone D; Tilden AB; Cloud G; Friedman HM; Landay A; Grossi CE
J Immunol Methods; 1986 Nov; 94(1-2):247-55. PubMed ID: 3782814
[TBL] [Abstract][Full Text] [Related]
35. Psychoneuroimmunology and natural killer cells: the chromium release whole blood assay.
Fletcher MA; Barnes Z; Broderick G; Klimas NG
Methods Mol Biol; 2012; 934():313-24. PubMed ID: 22933153
[TBL] [Abstract][Full Text] [Related]
36. Visualization and quantification of NK cell-mediated cytotoxicity over extended time periods by image cytometry.
Chan LL; Wucherpfennig KW; de Andrade LF
J Immunol Methods; 2019 Jun; 469():47-51. PubMed ID: 30951701
[TBL] [Abstract][Full Text] [Related]
37. Target-induced natural killer cell loss as a measure of NK cell responses.
Warren H
Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
39. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
40. A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity.
So EC; Sallin MA; Zhang X; Chan SL; Sahni L; Schulze DH; Davila E; Strome SE; Jain A
J Immunol Methods; 2013 Aug; 394(1-2):40-8. PubMed ID: 23680234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
